Download A Welsh overview of pharmacy and falls

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

Adherence management coaching wikipedia , lookup

Transcript
A Welsh Overview of Pharmacy and
Falls Prevention
Timothy Banner
All Wales Consultant Pharmacist Community Healthcare
Honorary Lecturer – Welsh School of Pharmacy, Cardiff
University
Major risk factors
•
•
•
•
•
History of falls
Postural hypotension
Alcohol
Poor vision
Hearing loss
•
•
•
•
•
Mobility/gait problems
Incontinence
Stroke
Low morale
Dementia
Polypharmacy
• More drugs = increased risk of falls
• Increasing age, illness = increased risk of
falls
• Increased risk factors = increased falls
How Medicines Can Cause Falls
•
•
•
•
•
•
•
•
•
•
Sedation, drowsiness
Hypoglycaemia
Confusion
Vestibular damage (tinnitus, deafness)
Orthostatic hypotension
Impaired postural stability
Visual impairment (blurred vision, dry eyes)
Drug induced Parkinsonism
Hypothermia
Dehydration
Brain (psychotropic drugs)
• Stopping psychotropic drugs can reduce
falls (risk v benefit)
• Taking a psychotropic medicine can
double the risk of falling
• ??? 2 or more psychotropic medicines
• Due to
• Drowsiness/slow reaction times
• Orthostatic hypotension
Heart and Circulation
• In older people systolic BP of 110mmHg or
less is associated with increased risk of
falls.
• Drugs which slow heart rate or reduce BP
can cause falls.
• Stopping cardiovascular medication
reduces syncope and risk of falls by 50%
(risk v benefit)
• Aims to address some of the problems associated with
the current management of polypharmacy, particularly in
the frail elderly
• The guideline also aims to summarise the expected
effectiveness of several of the main current medicines
strategies looking at:
• What benefit do various medicines strategies hope to
achieve?
• How many patients per annum need to be treated
with that medicine to obtain benefit for one patient?
• Where possible, how long is it estimated that
treatment was needed in therapeutic trials to show a
significant difference between being on that medicine
and not being on that medicine?
Medication Assessments
• Without assessment patients who are at
high risk for falls may receive medication
that will increase that risk
• May be recent changes but usually
medicines have been taken for a period of
time without review
• Older people may be more “sensitive” to
medicines due to pharmacokinetic
changes
Role of health care team
Steps required in minimizing the risks of falls
– Gather all medication information of patient
– Review each medication to identify any potential meds
that increase falls
– Monitor efficacy and adverse reactions
– Make necessary adjustments to medication in relation to
disease or patient’s reaction
– Resist the temptation to request/prescribe additional
medication to treat side effects
All Healthcare Providers need to be vigilant in medication
monitoring
Questions for review?
• Risk/Benefit ratio?
• Safer drug/non-pharmacological
alternative?
• Minimise dose v therapeutic benefit?
• Bone protection?
Counselling
• Taking medication at an inappropriate
time can increase the risk of falls
• E.g. taking diuretics late in the day, then
getting up at night to go to the toilet
• E.g. taking SSRIs at night, then needing
night sedation
Where can/do we do this?
Community Pharmacy
•
•
•
•
•
•
Accessibility
Regular Contact - deliveries
Advice – health campaigns
Signposting
MUR – Medicines Use Review
DMR – Discharge Medicines Review
• Limited/no access to clinical records
Primary/Community Care
•
•
•
•
GP practice based pharmacists
Cluster pharmacists
Medicines Management teams
Discharge/Community resource teams
• Scope to conduct medication reviews with
access to clinical records
Hospital Pharmacy
•
•
•
•
A&E
Admissions – medical/surgical
Fracture clinics
Rehabilitation wards
• Review medication with clinical records,
make changes/communicate with primary
care
• Medication linked to increased risk of
falling
• Opportunities for medication review
should be maximised
• Risk v benefit discussion is key to
prescribing/deprescribing
• Available tool to aid review
• NOTEARS, STOPP/START
• AWMSG guidance, Scottish guidance
Thank You
Any Questions?
[email protected]